Top 10 research priorities for irritable bowel syndrome: results of a James Lind Alliance priority setting partnership
- PMID: 36996852
- DOI: 10.1016/S2468-1253(23)00072-9
Top 10 research priorities for irritable bowel syndrome: results of a James Lind Alliance priority setting partnership
Conflict of interest statement
The James Lind Alliance priority setting partnership dealing with the diagnosis, treatment, and care of people with IBS was funded equally by Guts UK Charity and the British Society of Gastroenterology. We thank all the people with IBS, family members, carers, and health-care professionals who took part in this priority setting partnership, including the final workshop. ACF has received grants from Tillotts Pharma, consulting fees from Ironwood, and payment or honoraria for webinars from GE Healthcare and Sandoz. All other authors declared no competing interests.
Similar articles
-
What Are the Top 10 Research Questions in the Treatment of Inflammatory Bowel Disease? A Priority Setting Partnership with the James Lind Alliance.J Crohns Colitis. 2017 Feb;11(2):204-211. doi: 10.1093/ecco-jcc/jjw144. Epub 2016 Aug 9. J Crohns Colitis. 2017. PMID: 27506537 Free PMC article.
-
Rare musculoskeletal diseases in adults: a research priority setting partnership with the James Lind Alliance.Orphanet J Rare Dis. 2020 May 19;15(1):117. doi: 10.1186/s13023-020-01398-5. Orphanet J Rare Dis. 2020. PMID: 32430048 Free PMC article.
-
Research priorities to prevent and treat diabetic foot ulcers-A digital James Lind Alliance Priority Setting Partnership.Diabet Med. 2022 Nov;39(11):e14947. doi: 10.1111/dme.14947. Epub 2022 Sep 7. Diabet Med. 2022. PMID: 36054410 Free PMC article.
-
Priority III: top 10 rapid review methodology research priorities identified using a James Lind Alliance Priority Setting Partnership.J Clin Epidemiol. 2022 Nov;151:151-160. doi: 10.1016/j.jclinepi.2022.08.002. Epub 2022 Aug 28. J Clin Epidemiol. 2022. PMID: 36038041 Free PMC article.
-
Determining research priorities through partnership with patients: an overview.Semin Dial. 2015 Mar-Apr;28(2):141-6. doi: 10.1111/sdi.12325. Epub 2014 Nov 30. Semin Dial. 2015. PMID: 25440522 Review.
Cited by
-
Treating disorders of brain-gut interaction with multidisciplinary integrated care. Moving towards a new standard of care.JGH Open. 2024 May 20;8(5):e13072. doi: 10.1002/jgh3.13072. eCollection 2024 May. JGH Open. 2024. PMID: 38770352 Free PMC article. Review.
-
Microbiome-driven IBS metabotypes influence response to the low FODMAP diet: insights from the faecal volatome.EBioMedicine. 2024 Sep;107:105282. doi: 10.1016/j.ebiom.2024.105282. Epub 2024 Aug 22. EBioMedicine. 2024. PMID: 39173527 Free PMC article.
-
Genome-Wide DNA Methylation Identifies Potential Disease-Specific Biomarkers and Pathophysiologic Mechanisms in Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Celiac Disease.Neurogastroenterol Motil. 2025 Feb;37(2):e14980. doi: 10.1111/nmo.14980. Epub 2024 Dec 13. Neurogastroenterol Motil. 2025. PMID: 39673136 Free PMC article.
-
Common misconceptions and controversies in the management of irritable bowel syndrome.Nat Rev Gastroenterol Hepatol. 2025 Jul;22(7):517-526. doi: 10.1038/s41575-025-01065-9. Epub 2025 Apr 25. Nat Rev Gastroenterol Hepatol. 2025. PMID: 40281279 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources